1,8-Naphthyridine Derivatives : A Privileged Scaffold for Versatile Biological Activities
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
1, 8- Naphthyridine nucleus belongs to significant nitrogen-containing heterocyclic compounds which has garnered the interest of researchers due to its versatile biological activities. It is known to be used as an antimicrobial, anti-psychotic, anti-depressant, anti-convulsant, anti- Alzheimer's, anti-cancer, analgesic, anti-inflammatory, antioxidant, anti-viral, anti-hypertensive, antimalarial, pesticides, anti-platelets, and CB2 receptor agonist, etc. The present review highlights the framework of biological properties of synthesized 1, 8-naphthyridine derivatives developed by various research groups across the globe.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Mini reviews in medicinal chemistry - 21(2021), 5 vom: 02., Seite 586-601 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ojha, Madhwi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.07.2021 Date Revised 19.07.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1389557520666201009162804 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316088110 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316088110 | ||
| 003 | DE-627 | ||
| 005 | 20231225160325.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389557520666201009162804 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1053.xml |
| 035 | |a (DE-627)NLM316088110 | ||
| 035 | |a (NLM)33038911 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ojha, Madhwi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 1,8-Naphthyridine Derivatives |b A Privileged Scaffold for Versatile Biological Activities |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.07.2021 | ||
| 500 | |a Date Revised 19.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a 1, 8- Naphthyridine nucleus belongs to significant nitrogen-containing heterocyclic compounds which has garnered the interest of researchers due to its versatile biological activities. It is known to be used as an antimicrobial, anti-psychotic, anti-depressant, anti-convulsant, anti- Alzheimer's, anti-cancer, analgesic, anti-inflammatory, antioxidant, anti-viral, anti-hypertensive, antimalarial, pesticides, anti-platelets, and CB2 receptor agonist, etc. The present review highlights the framework of biological properties of synthesized 1, 8-naphthyridine derivatives developed by various research groups across the globe | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a 1 | |
| 650 | 4 | |a 8-Naphthyridine derivatives | |
| 650 | 4 | |a enoxacin | |
| 650 | 4 | |a gemifloxacin | |
| 650 | 4 | |a nalidixic acid | |
| 650 | 4 | |a tosufolxacin | |
| 650 | 4 | |a voreloxin | |
| 650 | 7 | |a Anti-Infective Agents |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Anticonvulsants |2 NLM | |
| 650 | 7 | |a Antidepressive Agents |2 NLM | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 650 | 7 | |a Fluoroquinolones |2 NLM | |
| 650 | 7 | |a Naphthyridines |2 NLM | |
| 650 | 7 | |a Thiazoles |2 NLM | |
| 650 | 7 | |a Enoxacin |2 NLM | |
| 650 | 7 | |a 325OGW249P |2 NLM | |
| 650 | 7 | |a Nalidixic Acid |2 NLM | |
| 650 | 7 | |a 3B91HWA56M |2 NLM | |
| 650 | 7 | |a tosufloxacin |2 NLM | |
| 650 | 7 | |a GHJ553KQPS |2 NLM | |
| 650 | 7 | |a vosaroxin |2 NLM | |
| 650 | 7 | |a K6A90IIZ19 |2 NLM | |
| 650 | 7 | |a Nitrogen |2 NLM | |
| 650 | 7 | |a N762921K75 |2 NLM | |
| 650 | 7 | |a Gemifloxacin |2 NLM | |
| 650 | 7 | |a OKR68Y0E4T |2 NLM | |
| 700 | 1 | |a Yadav, Divya |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Avinash |e verfasserin |4 aut | |
| 700 | 1 | |a Dasgupta, Suman |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Rakesh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mini reviews in medicinal chemistry |d 2001 |g 21(2021), 5 vom: 02., Seite 586-601 |w (DE-627)NLM121595404 |x 1875-5607 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:5 |g day:02 |g pages:586-601 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389557520666201009162804 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 5 |b 02 |h 586-601 | ||